Correction: mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company
- PMID: 38082358
- PMCID: PMC10714567
- DOI: 10.1186/s40545-023-00677-3
Correction: mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company
Erratum for
-
mRNA vaccine development during the COVID-19 pandemic: a retrospective review from the perspective of the Swiss affiliate of a global biopharmaceutical company.J Pharm Policy Pract. 2023 Nov 27;16(1):158. doi: 10.1186/s40545-023-00652-y. J Pharm Policy Pract. 2023. PMID: 38012751 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources